Is Becton, Dickinson and Company Stock Underperforming the S&P 500?
Despite Becton, Dickinson and Company’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.
| Ticker |
BDX
|
| CIK | 0000010795 |
| SIC | 3841 |
| Sector | Manufacturing |
| Industry Category | Medical Equipment |
| Industry Group | Surgical, Medical, And Dental Instruments And Supplies |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Is Becton, Dickinson and Company Stock Underperforming the S&P 500?Despite Becton, Dickinson and Company’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects. Becton, Dickinson and Company (NYSE:BDX) Shares Could Be 27% Above Their Intrinsic Value EstimateKey Insights The projected fair value for Becton Dickinson is US$149 based on 2 Stage Free Cash Flow to Equity Becton... BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening InitiativeIn recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE: BDX) is shining a spotlight on a serious yet often overlooked circulatory disorder that restricts blood flow to the limbs and is a leading cause of preventable amputations. Becton, Dickinson and Company (BDX) Generated Lower-Than-Expected Revenue in Q2First Eagle Investments, an investment management company, released its “First Eagle Global Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Class A shares of the fund returned 7.23% in the second quarter of 2025. All regions contributed to the overall performance. North America and developed Europe were the top […] Are Options Traders Betting on a Big Move in Becton Dickinson Stock?Investors need to pay close attention to Becton Dickinson stock based on the movements in the options market lately. |